Table 2. Five-year survival and prognostic factors after lung metastasectomy—important studies.
| Primary tumor | Period (years) | Total no. of patients (no. with R0) | 5-year survival (R0) % | Prognostic factors |
| Breast carcinoma | ||||
| Planchard 2004 (e45) | 1972–1998 | 125 (96) | 45 | Disease-free interval, size |
| Welter 2008 (12) | 1998–2007 | 47 | 36 | Receptor status |
| Chen 2009 (11) | 1991–2007 | 41 | 51 | Disease-free interval, number |
| Head and neck tumors | ||||
| Shiono 2009 (e46) | 1980–2006 | 114 | 26,5 | Sex, oral cancer, lymph node involvement, radicality |
| Winter 2008 (e47) | 1984–2006 | 67 (40) | 20.9 (27.7) | Radicality, perioperative complications, neoadjuvant treatment for the metastases |
| Chen F, et al. 2008 (e20) | 1991–2007 | (20) | (59.4) | Sex, disease-free interval, histology |
R0, resection status 0